(Q40695752)

English

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

scientific article published on 25 April 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease (English)

1 reference

Europe PubMed Central

22 September 2017

author name string

Hye Suk Hwang

1

1 reference

Europe PubMed Central

22 September 2017

Young-Tae Lee

2

1 reference

Europe PubMed Central

22 September 2017

Ki-Hye Kim

3

1 reference

Europe PubMed Central

22 September 2017

Soojin Park

4

1 reference

Europe PubMed Central

22 September 2017

Young-Man Kwon

5

1 reference

Europe PubMed Central

22 September 2017

Youri Lee

6

1 reference

Europe PubMed Central

22 September 2017

Eun-Ju Ko

7

1 reference

Europe PubMed Central

22 September 2017

Yu-Jin Jung

8

1 reference

Europe PubMed Central

22 September 2017

Jong Seok Lee

9

1 reference

Europe PubMed Central

22 September 2017

Yu-Jin Kim

10

1 reference

Europe PubMed Central

22 September 2017

Yu-Na Lee

11

1 reference

Europe PubMed Central

22 September 2017

Min-Chul Kim

12

1 reference

Europe PubMed Central

22 September 2017

Minkyoung Cho

13

1 reference

Europe PubMed Central

22 September 2017

Sang-Moo Kang

14

1 reference

Europe PubMed Central

22 September 2017

language of work or name

0 references

publication date

25 April 2016

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

494

1 reference

Europe PubMed Central

22 September 2017

215-224

1 reference

Europe PubMed Central

22 September 2017

The cotton rat model of respiratory viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Immunomodulatory activity of red ginseng against influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Immunopathology of RSV infection: prospects for developing vaccines without this complication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2016.04.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2016.04.014

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40695752&oldid=1904877293"